Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TSVT | 2seventy bio, Inc. | Jun 10, 2024 | 2 | $0 | 4 | Jun 12, 2024 | Director |
CHRS | Coherus BioSciences, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
TSVT | 2seventy bio, Inc. | Mar 20, 2024 | 2 | $0 | 4 | Mar 25, 2024 | Director |
TSVT | 2seventy bio, Inc. | Mar 20, 2024 | 0 | $0 | 3 | Mar 25, 2024 | Director |
LYEL | Lyell Immunopharma, Inc. | Feb 9, 2024 | 2 | $0 | 4 | Feb 13, 2024 | Chief Financial Officer |
LYEL | Lyell Immunopharma, Inc. | Nov 16, 2023 | 8 | $0 | 4 | Nov 20, 2023 | Chief Financial Officer |
CHRS | Coherus BioSciences, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
LYEL | Lyell Immunopharma, Inc. | Feb 24, 2023 | 1 | $0 | 4 | Feb 28, 2023 | Chief Financial Officer |
CHRS | Coherus BioSciences, Inc. | May 4, 2022 | 1 | $0 | 4 | May 6, 2022 | Director |
CHRS | Coherus BioSciences, Inc. | May 4, 2022 | 0 | $0 | 3 | May 6, 2022 | Director |
CHRS | Coherus BioSciences, Inc. | May 4, 2022 | 0 | $0 | 3 | May 6, 2022 | Director |
LYEL | Lyell Immunopharma, Inc. | Mar 16, 2022 | 1 | $0 | 4 | Mar 18, 2022 | Chief Financial Officer |
LYEL | Lyell Immunopharma, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Chief Financial Officer |